Back to Search
Start Over
Comments on Li H et al. 'A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma'
- Source :
- Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 36(1)
- Publication Year :
- 2014
-
Abstract
- With great interest, we read the article “A systematic review of matrix metalloproteinase 9 as a biomarker of survival in patients with osteosarcoma” (by Li H et al.). This article suggests that high expression of matrix metalloproteinase 9 (MMP-9) is associated with a poor prognosis for patients with osteosarcoma [1]. The result is encouraging. Nevertheless, some flaws existed in this meta-analysis that we would like to point out.
- Subjects :
- musculoskeletal diseases
Poor prognosis
Pathology
medicine.medical_specialty
Osteosarcoma
business.industry
Matrix metalloproteinase 9
Bone Neoplasms
General Medicine
medicine.disease
Matrix Metalloproteinase 9
Meta-analysis
Cancer research
Biomarkers, Tumor
Medicine
Biomarker (medicine)
Humans
In patient
business
Subjects
Details
- ISSN :
- 14230380
- Volume :
- 36
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
- Accession number :
- edsair.doi.dedup.....69c35c3763bee19bb87a04a0cc391c26